BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $278,847 | -24.3% | 6,875 | -4.8% | 0.03% | -26.1% |
Q4 2022 | $368,153 | -7.0% | 7,223 | -1.9% | 0.05% | -14.8% |
Q3 2022 | $396,000 | -16.3% | 7,361 | 0.0% | 0.05% | -10.0% |
Q2 2022 | $473,000 | -17.2% | 7,361 | 0.0% | 0.06% | 0.0% |
Q1 2022 | $571,000 | -9.7% | 7,361 | 0.0% | 0.06% | -10.4% |
Q4 2021 | $632,000 | +6.8% | 7,361 | 0.0% | 0.07% | +3.1% |
Q3 2021 | $592,000 | -32.6% | 7,361 | -32.5% | 0.06% | -30.1% |
Q2 2021 | $878,000 | -22.0% | 10,911 | -18.2% | 0.09% | -21.2% |
Q1 2021 | $1,125,000 | +4.7% | 13,334 | -0.5% | 0.12% | -18.1% |
Q4 2020 | $1,075,000 | -3.3% | 13,395 | -3.1% | 0.14% | -20.9% |
Q3 2020 | $1,112,000 | -6.6% | 13,825 | 0.0% | 0.18% | -2.7% |
Q2 2020 | $1,190,000 | +2.1% | 13,825 | -3.7% | 0.19% | -9.7% |
Q1 2020 | $1,165,000 | -5.4% | 14,355 | -2.5% | 0.21% | +59.2% |
Q4 2019 | $1,231,000 | -8.7% | 14,725 | -4.5% | 0.13% | -8.5% |
Q3 2019 | $1,349,000 | +13.1% | 15,425 | +5.9% | 0.14% | +22.4% |
Q2 2019 | $1,193,000 | +0.8% | 14,565 | 0.0% | 0.12% | +9.4% |
Q1 2019 | $1,184,000 | +23.5% | 14,565 | 0.0% | 0.11% | +10.4% |
Q4 2018 | $959,000 | -14.6% | 14,565 | 0.0% | 0.10% | +20.0% |
Q3 2018 | $1,123,000 | -11.2% | 14,565 | -15.0% | 0.08% | -8.0% |
Q2 2018 | $1,265,000 | +2.2% | 17,131 | -10.0% | 0.09% | +7.4% |
Q1 2018 | $1,238,000 | -9.8% | 19,031 | -10.4% | 0.08% | -3.6% |
Q4 2017 | $1,372,000 | +3.0% | 21,231 | 0.0% | 0.08% | +16.7% |
Q3 2017 | $1,332,000 | +2.5% | 21,231 | -1.1% | 0.07% | +14.3% |
Q2 2017 | $1,300,000 | +16.7% | 21,474 | 0.0% | 0.06% | +26.0% |
Q1 2017 | $1,114,000 | – | 21,474 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |